Species | Potential target | Raw | Global | Species |
---|---|---|---|---|
Trichomonas vaginalis | maltase-glucoamylase, putative | 0.0035 | 0.0791 | 1 |
Brugia malayi | Glycosyl hydrolases family 31 protein | 0.0158 | 0.3922 | 1 |
Schistosoma mansoni | cpg binding protein | 0.0028 | 0.0608 | 0.0608 |
Echinococcus granulosus | bloom syndrome protein | 0.0019 | 0.0388 | 0.0316 |
Trichomonas vaginalis | chromodomain-helicase-DNA-binding protein, putative | 0.0006 | 0.0059 | 0.0000000027566 |
Schistosoma mansoni | cpg binding protein | 0.003 | 0.0648 | 0.0648 |
Mycobacterium leprae | Probable 4-diphosphocytidyl-2C-methyl-D-erythritol synthase IspD (2-C-methyl-D-erythritol 4-phosphate cytidylyltransferase) (MEP | 0.0212 | 0.5274 | 0.5 |
Schistosoma mansoni | mixed-lineage leukemia protein mll | 0.0007 | 0.0074 | 0.0074 |
Trypanosoma cruzi | glycosyl hydrolase-like protein, putative | 0.0013 | 0.0231 | 0.1291 |
Schistosoma mansoni | mixed-lineage leukemia protein mll | 0.0059 | 0.1403 | 0.1403 |
Trichomonas vaginalis | alpha-glucosidase, putative | 0.0013 | 0.0231 | 0.2347 |
Trichomonas vaginalis | chromodomain helicase DNA binding protein, putative | 0.0006 | 0.0059 | 0.0000000027566 |
Trypanosoma brucei | ATP-dependent DEAD/H DNA helicase recQ, putative | 0.0019 | 0.0388 | 0.2801 |
Schistosoma mansoni | hypothetical protein | 0.0398 | 1 | 1 |
Loa Loa (eye worm) | glycosyl hydrolase family 31 protein | 0.0158 | 0.3922 | 1 |
Trypanosoma cruzi | hypothetical protein, conserved | 0.0035 | 0.0791 | 1 |
Loa Loa (eye worm) | hypothetical protein | 0.001 | 0.0148 | 0.0079 |
Loa Loa (eye worm) | RecQ helicase | 0.0019 | 0.0388 | 0.071 |
Entamoeba histolytica | glycosyl hydrolase, family 31 protein | 0.0035 | 0.0791 | 1 |
Echinococcus granulosus | histone lysine N methyltransferase MLL3 | 0.0009 | 0.0118 | 0.0044 |
Entamoeba histolytica | recQ family helicase, putative | 0.0019 | 0.0388 | 0.3821 |
Echinococcus multilocularis | bloom syndrome protein | 0.0019 | 0.0388 | 0.0316 |
Leishmania major | ATP-dependent DEAD/H DNA helicase recQ, putative | 0.0019 | 0.0388 | 0.2801 |
Trichomonas vaginalis | alpha-glucosidase, putative | 0.0035 | 0.0791 | 1 |
Onchocerca volvulus | 0.0092 | 0.2225 | 1 | |
Schistosoma mansoni | DNA helicase recq1 | 0.0019 | 0.0388 | 0.0388 |
Loa Loa (eye worm) | ATP-dependent DNA helicase | 0.0019 | 0.0388 | 0.071 |
Schistosoma mansoni | blooms syndrome DNA helicase | 0.001 | 0.0148 | 0.0148 |
Trichomonas vaginalis | chromodomain helicase DNA binding protein, putative | 0.0006 | 0.0059 | 0.0000000027566 |
Brugia malayi | CXXC zinc finger family protein | 0.0028 | 0.0608 | 0.1294 |
Trichomonas vaginalis | alpha-glucosidase, putative | 0.0035 | 0.0791 | 1 |
Trichomonas vaginalis | alpha-glucosidase, putative | 0.0013 | 0.0231 | 0.2347 |
Entamoeba histolytica | recQ family DNA helicase | 0.001 | 0.0148 | 0.0145 |
Echinococcus multilocularis | neutral alpha glucosidase AB | 0.0035 | 0.0791 | 0.0722 |
Loa Loa (eye worm) | glycosyl hydrolase family 31 protein | 0.0035 | 0.0791 | 0.177 |
Trypanosoma cruzi | glycosyl hydrolase-like protein, putative | 0.0013 | 0.0231 | 0.1291 |
Brugia malayi | ATP-dependent DNA helicase, RecQ family protein | 0.0019 | 0.0388 | 0.0717 |
Toxoplasma gondii | ATP-dependent DNA helicase, RecQ family protein | 0.0019 | 0.0388 | 0.1763 |
Echinococcus multilocularis | ATP dependent DNA helicase Q1 | 0.0019 | 0.0388 | 0.0316 |
Trichomonas vaginalis | maltase-glucoamylase, putative | 0.0013 | 0.0231 | 0.2347 |
Trichomonas vaginalis | chromodomain-helicase-DNA-binding protein, putative | 0.0006 | 0.0059 | 0.0000000027566 |
Echinococcus granulosus | ATP dependent DNA helicase Q5 | 0.0019 | 0.0388 | 0.0316 |
Treponema pallidum | hypothetical protein | 0.0065 | 0.1553 | 1 |
Brugia malayi | Bloom's syndrome protein homolog | 0.0019 | 0.0388 | 0.0717 |
Trichomonas vaginalis | neutral alpha-glucosidase ab precursor, putative | 0.0013 | 0.0231 | 0.2347 |
Echinococcus granulosus | cpg binding protein | 0.003 | 0.0648 | 0.0578 |
Loa Loa (eye worm) | hypothetical protein | 0.0013 | 0.0231 | 0.0297 |
Trichomonas vaginalis | DNA helicase recq1, putative | 0.0019 | 0.0388 | 0.449 |
Mycobacterium ulcerans | 2-C-methyl-D-erythritol 4-phosphate cytidylyltransferase | 0.0212 | 0.5274 | 0.5 |
Plasmodium falciparum | 2-C-methyl-D-erythritol 4-phosphate cytidylyltransferase, putative | 0.0065 | 0.1553 | 1 |
Trichomonas vaginalis | alpha-glucosidase, putative | 0.0035 | 0.0791 | 1 |
Echinococcus granulosus | neutral alpha glucosidase AB | 0.0035 | 0.0791 | 0.0722 |
Trichomonas vaginalis | DNA helicase recq, putative | 0.0019 | 0.0388 | 0.449 |
Schistosoma mansoni | alpha glucosidase | 0.0035 | 0.0791 | 0.0791 |
Toxoplasma gondii | glycosyl hydrolase, family 31 protein | 0.0035 | 0.0791 | 0.4614 |
Schistosoma mansoni | cpg binding protein | 0.003 | 0.0648 | 0.0648 |
Toxoplasma gondii | ATP-dependent DNA helicase, RecQ family protein | 0.001 | 0.0148 | 0.0067 |
Trichomonas vaginalis | DNA helicase recq, putative | 0.0019 | 0.0388 | 0.449 |
Brugia malayi | Glycosyl hydrolases family 31 protein | 0.0013 | 0.0231 | 0.0304 |
Schistosoma mansoni | alpha-glucosidase | 0.0136 | 0.3362 | 0.3362 |
Toxoplasma gondii | histone lysine methyltransferase SET1 | 0.0053 | 0.1242 | 0.7801 |
Leishmania major | alpha glucosidase II subunit, putative | 0.0035 | 0.0791 | 1 |
Loa Loa (eye worm) | hypothetical protein | 0.001 | 0.0148 | 0.0079 |
Entamoeba histolytica | glycosyl hydrolase, family 31 protein | 0.0035 | 0.0791 | 1 |
Mycobacterium tuberculosis | 4-diphosphocytidyl-2C-methyl-D-erythritol synthase IspD (MEP cytidylyltransferase) (MCT) | 0.0146 | 0.3619 | 0.5 |
Trichomonas vaginalis | alpha-glucosidase, putative | 0.0013 | 0.0231 | 0.2347 |
Trypanosoma cruzi | hypothetical protein, conserved | 0.0035 | 0.0791 | 1 |
Toxoplasma gondii | ATP-dependent DNA helicase, RecQ family protein | 0.0019 | 0.0388 | 0.1763 |
Echinococcus multilocularis | ATP dependent DNA helicase Q5 | 0.0019 | 0.0388 | 0.0316 |
Echinococcus multilocularis | cpg binding protein | 0.003 | 0.0648 | 0.0578 |
Echinococcus multilocularis | dnaJ subfamily B | 0.0398 | 1 | 1 |
Trichomonas vaginalis | alpha-glucosidase, putative | 0.0035 | 0.0791 | 1 |
Brugia malayi | Glycosyl hydrolases family 31 protein | 0.0035 | 0.0791 | 0.1776 |
Schistosoma mansoni | alpha-glucosidase | 0.0136 | 0.3362 | 0.3362 |
Trichomonas vaginalis | chromodomain helicase DNA binding protein, putative | 0.0006 | 0.0059 | 0.0000000027566 |
Echinococcus multilocularis | lysosomal alpha glucosidase | 0.0158 | 0.3922 | 0.3876 |
Trichomonas vaginalis | neutral alpha-glucosidase ab precursor, putative | 0.0035 | 0.0791 | 1 |
Schistosoma mansoni | blooms syndrome DNA helicase | 0.0009 | 0.0138 | 0.0138 |
Brugia malayi | ATP-dependent DNA helicase, RecQ family protein | 0.0019 | 0.0388 | 0.0717 |
Onchocerca volvulus | 0.0028 | 0.0608 | 0.1889 | |
Trypanosoma brucei | glucosidase, putative | 0.0035 | 0.0791 | 1 |
Entamoeba histolytica | glycosyl hydrolase, family 31 protein | 0.0013 | 0.0231 | 0.1418 |
Trypanosoma cruzi | ATP-dependent DEAD/H DNA helicase recQ, putative | 0.0019 | 0.0388 | 0.373 |
Trichomonas vaginalis | alpha-glucosidase, putative | 0.0013 | 0.0231 | 0.2347 |
Schistosoma mansoni | DNA helicase recq5 | 0.0019 | 0.0388 | 0.0388 |
Trichomonas vaginalis | alpha-glucosidase, putative | 0.0035 | 0.0791 | 1 |
Toxoplasma gondii | hypothetical protein | 0.0065 | 0.1553 | 1 |
Giardia lamblia | Sgs1 DNA helicase, putative | 0.0019 | 0.0388 | 0.5 |
Trichomonas vaginalis | alpha-glucosidase, putative | 0.0013 | 0.0231 | 0.2347 |
Wolbachia endosymbiont of Brugia malayi | 2-C-methyl-D-erythritol 2,4-cyclodiphosphate synthase | 0.0065 | 0.1553 | 0.5 |
Trichomonas vaginalis | sucrase-isomaltase, putative | 0.0035 | 0.0791 | 1 |
Trichomonas vaginalis | neutral alpha-glucosidase ab precursor, putative | 0.0035 | 0.0791 | 1 |
Trichomonas vaginalis | chromodomain helicase DNA binding protein, putative | 0.0006 | 0.0059 | 0.0000000027566 |
Trichomonas vaginalis | chromodomain helicase DNA binding protein, putative | 0.0006 | 0.0059 | 0.0000000027566 |
Loa Loa (eye worm) | CXXC zinc finger family protein | 0.0028 | 0.0608 | 0.1288 |
Echinococcus multilocularis | histone lysine N methyltransferase MLL3 | 0.0009 | 0.0118 | 0.0044 |
Echinococcus multilocularis | lysosomal alpha glucosidase | 0.0158 | 0.3922 | 0.3876 |
Echinococcus granulosus | lysosomal alpha glucosidase | 0.0158 | 0.3922 | 0.3876 |
Plasmodium vivax | 2-C-methyl-D-erythritol 4-phosphate cytidylyltransferase, putative | 0.0065 | 0.1553 | 1 |
Plasmodium vivax | ADP-dependent DNA helicase RecQ, putative | 0.001 | 0.0148 | 0.0067 |
Loa Loa (eye worm) | hypothetical protein | 0.0019 | 0.0388 | 0.071 |
Trichomonas vaginalis | chromodomain helicase DNA binding protein, putative | 0.0006 | 0.0059 | 0.0000000027566 |
Echinococcus granulosus | ATP dependent DNA helicase Q1 | 0.0019 | 0.0388 | 0.0316 |
Chlamydia trachomatis | 2-C-methyl-D-erythritol 4-phosphate cytidylyltransferase | 0.0212 | 0.5274 | 0.5 |
Trichomonas vaginalis | neutral alpha-glucosidase ab precursor, putative | 0.0013 | 0.0231 | 0.2347 |
Activity type | Activity value | Assay description | Source | Reference |
---|---|---|---|---|
Inhibition (functional) | = 0 % | GSK_TCMDC: Inhibition of Plasmodium falciparum 3D7 LDH activity, using an LDH reporter assay. Test compounds present at 2uM | ChEMBL. | 20485427 |
Inhibition (functional) | = 0.14 % | ST_JUDE_LEISH: Cytotoxicity at 2uM final concentration against transgenic Leishmania Mexicana promastigotes LmGT2 that are glucose transport deficient and complemented with the L. Mexicana glucose transporter 2. Activity is measured by by DNA content using SYBR green in vitro | ChEMBL. | No reference |
Inhibition (functional) | = 1.06 % | ST_JUDE_LEISH: Cytotoxicity at 2uM final concentration against transgenic Leishmania Mexicana promastigotes LmGLUT1 that are glucose transport deficient and complemented with the human glucose transporter GLUT1. Activity is measured by DNA content using SYBR green in vitro | ChEMBL. | No reference |
Inhibition (functional) | = 1.98 % | ST_JUDE_LEISH: Cytotoxicity at 2uM final concentration against transgenic Leishmania Mexicana promastigotes LmPfHT that are glucose transport deficient and complemented with the Plasmodium falciparum hexose transporter. Activity is measured by by DNA content using SYBR green in vitro | ChEMBL. | No reference |
Inhibition (functional) | = 4 % | GSK_TCMDC: Percent inhibition of human HepG2 cell line. Test compounds present at 10uM. | ChEMBL. | 20485427 |
Inhibition (functional) | = 92 % | GSK_TCMDC: Inhibition of Plasmodium falciparum Dd2 in whole red blood cells, using parasite LDH activity as an index of growth. Test compounds present at 2uM | ChEMBL. | 20485427 |
Inhibition (functional) | = 94 % | GSK_TCMDC: Inhibition of Plasmodium falciparum 3D7 in whole red blood cells, using parasite LDH activity as an index of growth. Test compounds present at 2uM | ChEMBL. | 20485427 |
Inhibition frequency index (IFI) (functional) | = 2.08 | Inhibition Frequency Index (IFI) | GSK. | 20485427 |
Percent growth inhibition (functional) | = -5 % | Percent inhibition of P. falciparum lactate dehydrogenase activity (at 2 uM) | GSK. | 20485427 |
Percent growth inhibition (functional) | = 4 % | Percent inhibition of HepG2 growth (at 10 uM) | GSK. | 20485427 |
Percent growth inhibition (functional) | = 92 % | Percent inhibition of P. falciparum Dd2 growth (at 2 uM) | GSK. | 20485427 |
Percent growth inhibition (functional) | = 94 % | Percent inhibition of P. falciparum 3D7 growth (at 2 uM) | GSK. | 20485427 |
XC50 (functional) | = 6.23 | XC50 determination of P. falciparum 3D7 growth | GSK. | 20485427 |
XC50 (functional) | = 0.58792 uM | GSK_TCMDC: Inhibition of Plasmodium falciparum 3D7 in whole erythrocytes, using parasite LDH activity as an index of growth. | ChEMBL. | 20485427 |
Many chemical entities in TDR Targets come from high-throughput screenings with whole cells or tissue samples, and not all assayed compounds have been tested against a single a single target protein, probably because they get ruled out during screening process. Even if these compounds may have not been of interest in the original screening, they may come as interesting leads for other screening assays. Furthermore, we may be able to propose drug-target associations using chemical similarities and network patterns.
1 literature reference was collected for this gene.